ZK 159222 is a synthetic cannabinoid receptor agonist investigated for potential therapeutic applications in pain management and the treatment of various neurological disorders. By interacting with the… Read more
ZK 159222 is a synthetic cannabinoid receptor agonist investigated for potential therapeutic applications in pain management and the treatment of various neurological disorders. By interacting with the endocannabinoid system and binding to CB1 receptors, this compound serves as a critical focus for pharmacological research. Pharmaceutical laboratories utilize this category of reference standards to support rigorous analytical testing and quality control protocols. The availability of stable isotope labelled compounds, including deuterated analogues, provides essential internal standards for mass spectrometry and chromatography, ensuring high precision in quantifying the parent drug within complex biological matrices. These materials are also vital for comprehensive impurity profiling and method validation, enabling researchers and analytical chemists to maintain strict quality standards while accurately identifying and characterizing related substances and metabolites throughout the drug development lifecycle.